L
Lahav Cohen
Researcher at Rosetta Genomics
Publications - 8
Citations - 391
Lahav Cohen is an academic researcher from Rosetta Genomics. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 5, co-authored 8 publications receiving 365 citations.
Papers
More filters
Journal ArticleDOI
Discovery of microRNAs and other small RNAs in solid tumors
Eti Meiri,Asaf Levy,Hila Benjamin,Miriam Ben-David,Lahav Cohen,Avital Dov,Nir Dromi,Eran Elyakim,Noga Yerushalmi,Orit Zion,Gila Lithwick-Yanai,Einat Sitbon +11 more
TL;DR: The sequencing of small RNAs from 23 breast, bladder, colon and lung tumor samples using high throughput sequencing is reported, and dozens of new miRNA sequence variants are identified that demonstrate the existence of miRNA-related SNP or post-transcriptional modifications.
Journal ArticleDOI
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.
Hila Benjamin,Danit Lebanony,Shai Rosenwald,Lahav Cohen,Hadas Gibori,Naama Barabash,Karin Ashkenazi,Eran Goren,Eti Meiri,Sara Morgenstern,Sara Morgenstern,Marina Perelman,Marina Perelman,Iris Barshack,Iris Barshack,Yaron Goren,Tina Bocker Edmonston,Ayelet Chajut,Ranit Aharonov,Zvi Bentwich,Nitzan Rosenfeld,Dalia Cohen +21 more
TL;DR: A standardized diagnostic assay based on the expression of microRNAs differentially expressed between MPM and various carcinomas can provide a useful tool in the differential diagnosis of MPM from other malignancies in the pleura.
Journal ArticleDOI
MicroRNA expression differentiates between primary lung tumors and metastases to the lung
Iris Barshack,Gila Lithwick-Yanai,Arnon Afek,Arnon Afek,Kinneret Rosenblatt,Kinneret Rosenblatt,Hila Tabibian-Keissar,Merav Zepeniuk,Lahav Cohen,Harel Dan,Orit Zion,Yulia Strenov,Sylvie Polak-Charcon,Sylvie Polak-Charcon,Marina Perelman,Marina Perelman +15 more
TL;DR: It is shown that microRNAs can serve as biomarkers for lung tumor classification and should be considered as a potential clinical biomarker for surgical pathologists faced with discerning the tumor type of an inscrutable lung neoplasm.
Journal ArticleDOI
Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
Iris Barshack,Eti Meiri,Shai Rosenwald,Danit Lebanony,Meital Bronfeld,Sarit Aviel-Ronen,Sarit Aviel-Ronen,Kinneret Rosenblatt,Kinneret Rosenblatt,Sylvie Polak-Charcon,Sylvie Polak-Charcon,Ilit Leizerman,Meital Ezagouri,Merav Zepeniuk,Norberto Shabes,Lahav Cohen,Sarit Tabak,Dalia Cohen,Zvi Bentwich,Nitzan Rosenfeld +19 more
TL;DR: The tissue-specific expression patterns of microRNAs make them useful biomarkers for the diagnosis of liver malignancies, as well as identifying primary hepatocellular carcinoma from metastatic adenocarcinoma in the liver.
Journal ArticleDOI
A second-generation microRNA-based assay for diagnosing tumor tissue origin.
Ranit Aharonov,Shai Rosenwald,Tina Bocker Edmonston,Iris Barshack,Meora Feinmesser,Monica Huszar,Wolf Mueller,Franz Fogt,H. Shomin,Lahav Cohen,Ilanit Burnstein,Eran Goren,B. St. Cyr,Yael Spector,Nir Dromi,Eti Meiri +15 more
TL;DR: The development and validation of a second generation clinical assay that can identify 42 different tumor types using a custom array platform is presented.